BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share (ORMP)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share
Symbol: ORMP
Shares outstanding: 40,364,992 shares
Disclosed Ownership: 2,643,907 shares
Ownership: 6.55%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 16:41:48 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	6.55%	2,643,907	0	2,643,907	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member